Importantly, enhanced tumor recognition was restricted to CD4+ TEG011_CD8α cells and not CD4+ TEGLM1_CD8α mock cells, highlighting the specific role of CD8α as co-stimulation for the introduced FE11 γδTCR. The gene discussed is CD4; the disease is neoplasm.